eGenesis

eGenesis is a biotechnology company focused on developing genetically engineered pigs to help address the global organ shortage for transplantation. Using advanced gene-editing technology, they modify pigs to produce organs that are less likely to be rejected by the human immune system. Their goal is to create safe, reliable animal organs that can be transplanted into humans, potentially saving lives and improving outcomes for patients waiting for transplants. By combining science and innovation, eGenesis aims to make organ rejection and scarcity less of a problem in medicine.